Skip to content

Evaluation of anti-microbial effect of Ayurvedic vaginal tablet in treatment of leucorrhea using animal experiments and human trials

Multi-dimensional scientific evaluation including in-vitro & in-vivo assessment and standardization of Ayurvedic vaginal tablets (Code-NA) for the treatment of Leucorrhea (excessive and abnormal vaginal discharge)

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/017986
Enrollment
100
Registered
2019-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Continuous per vaginal excessive abnormalwhite discharge exceptovulationperiod in Female patients, Itching around external genital parts, Pain in back, Constipation,Loss ofappetite,Painful intercourse

Interventions

Intervention1: Ayurvedic mucoadhesive vaginal tablet combination of stem bark of Neem (Azadirechta indica )and Asoka (saraca asoka) : One vaginal tablet per day up to 15 days Control Interventio

Sponsors

Institute of Post Graduate Ayurvedic Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Continuous per vaginal excessive abnormal white discharge except ovulation period 2 Itching around the external genital parts 3 Pain in the back region 4 Painful intercourse

Exclusion criteria

Exclusion criteria: 1 Pregnancy 2 History of significant per vaginal bleeding 3 prolapsed of uterus 4 Malignancy in the internal genital parts 5 Allergy to known constituents 6 Severely ill patients

Design outcomes

Primary

MeasureTime frame
Reduction in excessive abnormal vaginal discharge and associated symptoms, improvement in genital health condition and well beings.Timepoint: Day 1 Day 15

Secondary

MeasureTime frame
The primary outcome will be justified on the basis of vaginal fluid study, microbiological study, Routine haematological investigation and also urine in this studyTimepoint: Day 1 Day 15

Countries

India

Contacts

Public ContactDr Mradu Gupta

Department of Health & Family Welfare, Govt. of West Bengal

mradu_gupta@hotmail.com9433665125

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026